You’ve battled and beaten back a bout of cancer, so now you can take comfort in your victory, right? Wrong, claims new research that found most cancer patients and survivors fear their disease will return once treatment ends, a new analysis shows. Researchers reviewed 46 studies from 13 countries and found that 59% of cancer… read on > read on >
Black Americans are far less likely to be included in clinical trials of pancreatic cancer drugs than white Americans, and eligibility criteria are a significant factor in that gap, according to a new study. “The standard of care in cancer treatment is informed by studies conducted with predominantly non-Hispanic white patients,” said study author Dr.… read on > read on >
Immune system-triggered inflammation is the likely reason for the loss of smell reported by many COVID-19 patients, a new study finds. “As a neuropathologist, I wondered why smell loss is a very common symptom with COVID-19 but not with other respiratory diseases,” said lead study author Dr. Cheng-Ying Ho. She is an associate professor of… read on > read on >
Even as the COVID-19 pandemic kept people isolated at home, sexually transmitted disease (STDs) cases increased across the United States. Although cases fell in the pandemic’s early months, infections rose again by the end of 2020, with gonorrhea, syphilis and congenital syphilis surpassing 2019 levels, according to a new U.S. Centers for Disease Control and… read on > read on >
Certain personality traits may make older adults more or less vulnerable to waning memory and thinking skills, a new study suggests. The study, of nearly 2,000 older adults, found that those high on the “conscientious” scale — organized, self-disciplined and productive — were less likely to develop mild cognitive impairment. That refers to subtler problems… read on > read on >
Psilocybin — the active component in “magic mushrooms” — may help rewire the brains of people with depression. Psychedelics including psilocybin have shown promise in treating many mental health disorders in recent years, and a new study is among the first to begin to unravel precisely how they work. “The brain becomes more open and… read on > read on >
TUESDAY, April 12, 2022 (American Heart Association News) — At their babies’ 20-week ultrasound, Bridget and Jerrid Conway were eager to catch another glimpse of their twin girls. In the exam room, the technician moved the wand over Bridget’s stomach. When she lingered over Twin A, or Sadie as they later named her, the Conways… read on > read on >
Faced with rising COVID-19 case counts, Philadelphia has announced that it will reinstate an indoor mask mandate next week. City officials announced the change on Monday, as COVID-19 cases have climbed across the country due to the highly transmissible Omicron subvariant known as BA.2. Philadelphia has an automatic indoor mask mandate that kicks in whenever… read on > read on >
An experimental medication for critically ill COVID-19 patients appears to work so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. The medication, sabizabulin, halved the death rate in COVID-19 patients who were receiving supplemental oxygen and were at high risk of serious… read on > read on >
In their search for a drug to prevent Alzheimer’s disease, scientists are taking a look at certain rheumatoid arthritis drugs. Preliminary findings suggest that a type of rheumatoid arthritis drug known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients who also suffer from heart disease. But no one is suggesting these drugs… read on > read on >
